What's Next: Expanding Into Compounding Pharmacy

In late summer 2026, I'm opening my own compounding pharmacy in downtown Toronto.

Non-sterile compounding is a specialization that allows pharmacists to prepare customized medications — the right dose, the right formulation, the right delivery method — for patients who can't be served by mass-manufactured drugs. It's a space that requires significant training, precise standards, and a commitment to patient care above convenience.

I recently completed hands-on lab training in Montreal and I'm deep in the process of securing a location. This has been in the works for years. It's the natural next step after nearly a decade in pharmacy.

Why Compounding?

Standard pharmacy is a volume game. More prescriptions, faster turnaround, thinner margins. Compounding is different — it's a precision service that requires expertise, not just throughput. It serves patients that the mainstream system underserves. Dermatology, pain management, hormone therapy, pediatric formulations, veterinary medicine — these patients need medications tailored to them, not the average.

That specificity is valuable. And it aligns with how I've always approached my work: find the underserved need, build the capability to serve it well, and execute with precision.

What This Means

This is a new business I own outright. It's the beginning of what I intend to build into a multi-location pharmacy network over the next decade. The first location proves the model. What comes next depends on how well we execute the first one.

I'll document the journey here — the challenges, the decisions, the lessons. Building a regulated healthcare business in Canada is not simple. But it's worth doing right.

More updates to come.